Literature DB >> 10525118

F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo.

D Praticò1.   

Abstract

Isoprostanes are members of a complex family of lipids, isomers of the conventional enzymatically derived prostaglandins (PG), which are produced in vivo primarily, if not exclusively, by a free radical-catalyzed peroxidation of polyunsaturated fatty acids. Most of the work has been focused upon a group of isomers of the enzyme-derived PGF(2alpha), called F(2)-isoprostanes (F(2)-iPs). Because of their mechanism of formation, chemical stability and the rapid development of sensitive methods for their measurement, they have the attraction as non-invasive indices of oxidant stress in vivo. Altered generation of F(2)-iPs has been reported in a variety of clinical settings putatively associated with oxidant stress. These include atherosclerosis, chronic obstructive pulmonary disease and Alzheimer's disease. Furthermore, the measurement of specific F(2)-iPs may provide a sensitive biochemical basis for rational dose-selection of natural and synthetic inhibitor of lipid peroxidation. Although F(2)-iPs possess biological activities in vitro and in vivo, much remains to be learned about their role and as mediators of the cellular effects of lipid peroxidation and oxidant stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525118     DOI: 10.1016/s0021-9150(99)00257-9

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  27 in total

1.  Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Authors:  Kunihiro Uryu; Helmut Laurer; Tracy McIntosh; Domenico Praticò; Daniel Martinez; Susan Leight; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 2.  In vivo measurement of the redox state.

Authors:  D Praticò
Journal:  Lipids       Date:  2001       Impact factor: 1.880

Review 3.  The role of biomarkers in clinical trials for Alzheimer disease.

Authors:  Leon J Thal; Kejal Kantarci; Eric M Reiman; William E Klunk; Michael W Weiner; Henrik Zetterberg; Douglas Galasko; Domenico Praticò; Sue Griffin; Dale Schenk; Eric Siemers
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

Review 4.  Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.

Authors:  Rami Khayat; Brian Patt; Don Hayes
Journal:  Heart Fail Rev       Date:  2008-09-20       Impact factor: 4.214

5.  Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

Authors:  D Praticò; K Uryu; S Leight; J Q Trojanoswki; V M Lee
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

6.  Pre-diagnostic urinary 15-F2t -isoprostane level and liver cancer risk: Results from the Shanghai Women's and Men's Health Studies.

Authors:  Xiao Ma; Yu-Ting Tan; Yang Yang; Jing Gao; Hong-Lan Li; Wei Zheng; Qing Lan; Nathaniel Rothman; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2018-08-10       Impact factor: 7.396

7.  Effect of short-term low-intensity exercise training on association of oxygen free radicals and nitric oxide production in patients with acute myocardial infarction.

Authors:  Faisal Baraas; Lily Rilantono; Sri Diniharini; Iwan Kurniawan; Roy Christian; Dede Kusmana
Journal:  Int J Angiol       Date:  2013-09

Review 8.  Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family?

Authors:  Harold J Ting; Fadi T Khasawneh
Journal:  J Biomed Sci       Date:  2010-04-06       Impact factor: 8.410

9.  Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro.

Authors:  Sherry L Spinelli; Katie L Lannan; Ann E Casey; Amanda Croasdell; Timothy M Curran; Kelly F Henrichs; Stephen J Pollock; Ginger A Milne; Majed A Refaai; Charles W Francis; Richard P Phipps; Neil Blumberg
Journal:  Transfusion       Date:  2013-11-05       Impact factor: 3.157

10.  Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.

Authors:  Rachel Mistur; Lisa Mosconi; Susan De Santi; Marla Guzman; Yi Li; Wai Tsui; Mony J de Leon
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.